<?xml version="1.0" encoding="UTF-8"?>
<p>Which is primarily used in HIV has shown 
 <italic>in vitro</italic> activity in CoV-1. The experience on the clinical use of this combination in CoV-2 is mainly limited to case reports. A controlled trial from China on 99 patients with COVID-19 has failed to show its significant effect on mortality or time to clinical improvement.[
 <xref rid="ref21" ref-type="bibr">21</xref>]
</p>
